Gait disorders in CKD patients: muscle wasting or cognitive impairment? A cross-sectional pilot study to investigate gait signatures in Stage 1-5 CKD patients.
Chronic kidney disease
Cognitive impairment
Functional decline
Gait disorders
Gait variability
Sarcopenia
Journal
BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793
Informations de publication
Date de publication:
21 02 2022
21 02 2022
Historique:
received:
07
06
2021
accepted:
27
01
2022
entrez:
22
2
2022
pubmed:
23
2
2022
medline:
11
3
2022
Statut:
epublish
Résumé
Instrumental gait analysis in nephrology is widely neglected, although patients with chronic kidney disease (CKD) show brain changes due to cerebrovascular disease and metabolic disorders that can potentially influence gait quality. Our study assesses the association between CKD stages and gait parameters, to understand the prevalent status of brain related gait parameters (i.e. variability) and of performance related parameters (i.e. gait speed, stride length). We hypothesize that gait changes are detectable already in early stages of CKD. Forty-five participants distributed in 5 CKD severity groups underwent an instrumental gait analysis via a triaxial accelerometer affixed to the lower trunk under single- and dual-task conditions. In addition to spatio-temporal parameters, variability and dual-task cost of gait were extracted. A battery of clinical assessments was conducted with the aim of helping to better explain the findings of the gait analysis. A correlation analysis was made to investigate a linear relation between gait parameters and CKD severity. Statistically significant correlations (Pearson correlation coefficient) with CKD severity were found for gait speed (p < 0.01, r = -0.55, 95% CI [-0.73;-0.30]), stride length ( p < 0.01, r = -0.40, 95% CI [-0.62;-0.12]), step length (p < 0.01, r = -0.41, 95% CI [-0.63;-0.13], coefficient of variance (CV) of step length (p = 0.01, r = 0.36, 95% CI [0.08;0.59]), gait regularity (p < 0.01, r = -0.38, 95% CI [-0.61;-0.10]), dual-task cost of gait speed (p < 0.01, r = 0.40, 95% CI [0.13;0.62]) and dual-task cost of stride time (p = 0.03, r = 0.32, 95% CI [0.03;0.57]). Adjustment for age and gender confirmed all results except for gait regularity. With increasing severity of renal failure, Handgrip strength, Time for the Expanded Timed Get Up and Go test, executive functions, haemoglobin, and haematocrit, worsen. The correlation of CKD severity with spatio-temporal parameters (performance indices mainly relatable to peripheral functionality) and with variability of gait (related to central factors) supported by the results of the clinical assessments, suggests that gait disturbance in CKD patients is not only due to metabolic factors that lead to muscle wasting, but also to brain changes that affect motor control. This suggests that the treatment of renal disease should include cognitive aspects in addition to metabolic and functional factors.
Sections du résumé
BACKGROUND
Instrumental gait analysis in nephrology is widely neglected, although patients with chronic kidney disease (CKD) show brain changes due to cerebrovascular disease and metabolic disorders that can potentially influence gait quality. Our study assesses the association between CKD stages and gait parameters, to understand the prevalent status of brain related gait parameters (i.e. variability) and of performance related parameters (i.e. gait speed, stride length). We hypothesize that gait changes are detectable already in early stages of CKD.
METHODS
Forty-five participants distributed in 5 CKD severity groups underwent an instrumental gait analysis via a triaxial accelerometer affixed to the lower trunk under single- and dual-task conditions. In addition to spatio-temporal parameters, variability and dual-task cost of gait were extracted. A battery of clinical assessments was conducted with the aim of helping to better explain the findings of the gait analysis. A correlation analysis was made to investigate a linear relation between gait parameters and CKD severity.
RESULTS
Statistically significant correlations (Pearson correlation coefficient) with CKD severity were found for gait speed (p < 0.01, r = -0.55, 95% CI [-0.73;-0.30]), stride length ( p < 0.01, r = -0.40, 95% CI [-0.62;-0.12]), step length (p < 0.01, r = -0.41, 95% CI [-0.63;-0.13], coefficient of variance (CV) of step length (p = 0.01, r = 0.36, 95% CI [0.08;0.59]), gait regularity (p < 0.01, r = -0.38, 95% CI [-0.61;-0.10]), dual-task cost of gait speed (p < 0.01, r = 0.40, 95% CI [0.13;0.62]) and dual-task cost of stride time (p = 0.03, r = 0.32, 95% CI [0.03;0.57]). Adjustment for age and gender confirmed all results except for gait regularity. With increasing severity of renal failure, Handgrip strength, Time for the Expanded Timed Get Up and Go test, executive functions, haemoglobin, and haematocrit, worsen.
CONCLUSIONS
The correlation of CKD severity with spatio-temporal parameters (performance indices mainly relatable to peripheral functionality) and with variability of gait (related to central factors) supported by the results of the clinical assessments, suggests that gait disturbance in CKD patients is not only due to metabolic factors that lead to muscle wasting, but also to brain changes that affect motor control. This suggests that the treatment of renal disease should include cognitive aspects in addition to metabolic and functional factors.
Identifiants
pubmed: 35189838
doi: 10.1186/s12882-022-02697-8
pii: 10.1186/s12882-022-02697-8
pmc: PMC8862207
doi:
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
72Informations de copyright
© 2022. The Author(s).
Références
Can Geriatr J. 2018 Jun 30;21(2):157-165
pubmed: 29977431
BMC Nephrol. 2019 Mar 6;20(1):83
pubmed: 30841868
Arch Gerontol Geriatr. 2020 Mar - Apr;87:103976
pubmed: 31743824
Nephrol Dial Transplant. 2017 Feb 1;32(2):299-306
pubmed: 28186575
Stroke. 2011 Feb;42(2):494-7
pubmed: 21164137
Neurosci Biobehav Rev. 2019 May;100:344-369
pubmed: 30552912
J Gerontol A Biol Sci Med Sci. 2013 Apr;68(4):409-11
pubmed: 23401565
Int Urol Nephrol. 2017 Nov;49(11):1989-1997
pubmed: 28229311
Panminerva Med. 2012 Sep;54(3):189-204
pubmed: 22801436
J Gerontol A Biol Sci Med Sci. 2009 Sep;64(9):975-82
pubmed: 19429702
Ann Rehabil Med. 2017 Feb;41(1):72-79
pubmed: 28289638
J Cachexia Sarcopenia Muscle. 2017 Feb;8(1):57-68
pubmed: 27897415
Acta Obstet Gynecol Scand. 2018 Apr;97(4):388-393
pubmed: 29453895
BMC Nephrol. 2013 Oct 16;14:224
pubmed: 24131569
Neurol Sci. 2014 Apr;35(4):601-4
pubmed: 24366243
Gait Posture. 2011 Feb;33(2):233-7
pubmed: 21193313
Clin J Am Soc Nephrol. 2019 Jul 5;14(7):983-993
pubmed: 31235462
PLoS One. 2016 Mar 28;11(3):e0151037
pubmed: 27018891
Neurosci Biobehav Rev. 2017 Mar;74(Pt A):149-162
pubmed: 28115194
BMC Geriatr. 2015 Jul 01;15:72
pubmed: 26126532
Int J Rehabil Res. 2014 Mar;37(1):29-33
pubmed: 23873223
Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2181-9
pubmed: 26573615
Clin J Am Soc Nephrol. 2021 May 8;16(5):694-704
pubmed: 33824156
Indian J Dermatol. 2016 May-Jun;61(3):261-4
pubmed: 27293245
Neth J Med. 2014 Dec;72(10):509-15
pubmed: 26219755
Sensors (Basel). 2019 Jan 26;19(3):
pubmed: 30691154
J Nephrol. 2021 Aug;34(4):1347-1372
pubmed: 32876940
J Frailty Aging. 2019;8(1):7-9
pubmed: 30734824
J Am Soc Nephrol. 2013 Apr;24(5):689-90
pubmed: 23599383
Eur J Appl Physiol. 2004 Jun;92(1-2):39-44
pubmed: 14985994
Age Ageing. 2006 Nov;35(6):619-24
pubmed: 17047008
J Am Soc Nephrol. 2013 Feb;24(3):353-63
pubmed: 23291474
Neurosci Biobehav Rev. 2020 Jan;108:24-33
pubmed: 31639377
J Gerontol A Biol Sci Med Sci. 2013 Apr;68(4):412-8
pubmed: 22987797
Am J Kidney Dis. 2011 Jan;57(1):101-12
pubmed: 21184919
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Mov Disord. 2006 Jul;21(7):950-7
pubmed: 16541455
Kidney Int. 2010 Dec;78(11):1164-70
pubmed: 20811334
Am J Kidney Dis. 1994 Sep;24(3):480-5
pubmed: 8079973
J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):1009-1015
pubmed: 31066999
Ann Intern Med. 2007 Oct 16;147(8):W163-94
pubmed: 17938389
Clin Nephrol. 2011 Mar;75(3):218-25
pubmed: 21329632
J Neural Transm (Vienna). 2013 Jul;120(7):1083-92
pubmed: 23196981
Clin Kidney J. 2014 Jun;7(3):257-63
pubmed: 25852886
Age Ageing. 2019 Jul 1;48(4):601
pubmed: 31081853
J Ren Nutr. 2011 May;21(3):226-34
pubmed: 21055966
Arch Phys Med Rehabil. 2020 Aug;101(8):1377-1382
pubmed: 32416151
Physiol Rep. 2020 Feb;8(4):e14378
pubmed: 32109345
Gait Posture. 2016 Jun;47:31-6
pubmed: 27264399
Clin Kidney J. 2018 Apr;11(2):236-245
pubmed: 29644065
Wien Klin Wochenschr. 2017 Feb;129(3-4):81-95
pubmed: 27770207
Biol Pharm Bull. 2019;42(9):1437-1445
pubmed: 31474705
Nephrol Dial Transplant. 2018 Dec 1;33(12):2165-2172
pubmed: 29566168
Am J Kidney Dis. 2010 Oct;56(4):615-8
pubmed: 20851318
J Cardiopulm Rehabil Prev. 2018 May;38(3):147-158
pubmed: 29120966
J Physiol. 2018 Apr 1;596(7):1199-1210
pubmed: 29344967
Am J Kidney Dis. 2017 Jul;70(1):76-83
pubmed: 28139394
J Gerontol A Biol Sci Med Sci. 2021 Sep 13;76(10):1882-1890
pubmed: 33824986
Front Aging Neurosci. 2018 Dec 18;10:419
pubmed: 30618725
J Ren Nutr. 2012 Jul;22(4):423-33
pubmed: 22227183
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Nephrol Dial Transplant. 2012 Jan;27(1):352-7
pubmed: 21652549
Arch Phys Med Rehabil. 1995 Jun;76(6):547-51
pubmed: 7763154
Am J Kidney Dis. 2013 Feb;61(2):271-8
pubmed: 23040011
Aging Clin Exp Res. 2006 Apr;18(2):174-6
pubmed: 16702791
Front Aging Neurosci. 2017 Nov 29;9:390
pubmed: 29249961
Front Neurol. 2019 Apr 05;10:313
pubmed: 31024419
J Aging Res. 2012;2012:954378
pubmed: 22900182
Am J Nephrol. 2007;27(3):279-86
pubmed: 17440263
Hum Mov Sci. 2016 Jun;47:197-208
pubmed: 27023045
Front Physiol. 2020 Sep 04;11:565023
pubmed: 33013483
Nephrology (Carlton). 2019 Jan;24(1):50-55
pubmed: 28949427
Brain. 2011 Jan;134(Pt 1):73-83
pubmed: 21156660
Arch Phys Med Rehabil. 2013 Jan;94(1):127-31
pubmed: 22858796
QJM. 2011 Oct;104(10):829-38
pubmed: 21750022
Kidney Int. 2003 Jan;63(1):291-7
pubmed: 12472795
Alzheimers Dement. 2021 Aug;17(8):1317-1328
pubmed: 33590967
Neurology. 1993 Nov;43(11):2412-4
pubmed: 8232972
Am J Kidney Dis. 2007 Jul;50(1):8-10
pubmed: 17591520
Front Hum Neurosci. 2017 Aug 03;11:353
pubmed: 28824393
J Am Geriatr Soc. 2004 Nov;52(11):1863-9
pubmed: 15507063
J Clin Med. 2020 Mar 06;9(3):
pubmed: 32155951
Am J Kidney Dis. 2015 May;65(5):737-47
pubmed: 25542415